EROS/CYBC1 mutations: Decreased NADPH oxidase function and chronic granulomatous disease.
暂无分享，去创建一个
Anneliese O. Speak | Kenneth G. C. Smith | A. Speak | S. Clare | T. Chatila | F. Alkuraya | James C. Lee | A. Thrasher | G. Santilli | L. Charbonnier | H. Al-Mousa | Andrea Schejtman | H. Aldhekri | E. Coomber | Elizabeth R. Dufficy | Anne E. Beenken | D. Thomas | Eve L. Coomber | Hasan Aldhekri
[1] F. Alkuraya,et al. The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes , 2017, Human Genetics.
[2] Kenneth G. C. Smith,et al. Eros is a novel transmembrane protein that controls the phagocyte respiratory burst and is essential for innate immunity , 2017, The Journal of experimental medicine.
[3] J. Casanova,et al. Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases. , 2016, The Journal of allergy and clinical immunology.
[4] J. Church,et al. Hemophagocytic lymphohistiocytosis in children with chronic granulomatous disease , 2011, Pediatric blood & cancer.
[5] Dirk Roos,et al. Chronic Granulomatous Disease: The European Experience , 2009, PloS one.
[6] A. Segal,et al. How neutrophils kill microbes. , 2005, Annual review of immunology.